The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Inspire Medical Systems Inc (NYSE: INSP) closed at $86.32 up 0.84% from its previous closing price of $85.6. In other words, the price has increased by $0.84 from its previous closing price. On the day, 0.96 million shares were traded. INSP stock price reached its highest trading level at $87.8999 during the session, while it also had its lowest trading level at $84.38.
Ratios:
For a deeper understanding of Inspire Medical Systems Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.03. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on September 02, 2025, initiated with a Outperform rating and assigned the stock a target price of $150.
On August 05, 2025, Truist Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $125.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 29 ’25 when Buchholz Richard sold 11,000 shares for $93.39 per share. The transaction valued at 1,027,290 led to the insider holds 44,867 shares of the business.
Buchholz Richard bought 11,000 shares of INSP for $1,027,349 on Aug 29 ’25. On May 19 ’25, another insider, Rondoni John, who serves as the insider of the company, sold 1,734 shares for $149.38 each. As a result, the insider received 259,025 and left with 13,766 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2552853504 and an Enterprise Value of 2285018880. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 50.01, and their Forward P/E ratio for the next fiscal year is 55.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.96 while its Price-to-Book (P/B) ratio in mrq is 3.77. Its current Enterprise Value per Revenue stands at 2.653 whereas that against EBITDA is 43.785.
Stock Price History:
The Beta on a monthly basis for INSP is 1.21, which has changed by -0.56156033 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $225.00, while it has fallen to a 52-week low of $73.92. The 50-Day Moving Average of the stock is -22.48%, while the 200-Day Moving Average is calculated to be -44.12%.
Shares Statistics:
For the past three months, INSP has traded an average of 963.95K shares per day and 924800 over the past ten days. A total of 29.57M shares are outstanding, with a floating share count of 26.72M. Insiders hold about 9.66% of the company’s shares, while institutions hold 106.60% stake in the company. Shares short for INSP as of 1755216000 were 2291236 with a Short Ratio of 2.38, compared to 1752537600 on 3290632. Therefore, it implies a Short% of Shares Outstanding of 2291236 and a Short% of Float of 10.3999995.
Earnings Estimates
The firm’s stock currently is rated by 13.0 analysts. The consensus estimate for the next quarter is $0.67, with high estimates of $0.74 and low estimates of $0.55.
Analysts are recommending an EPS of between $1.08 and $0.4 for the fiscal current year, implying an average EPS of $0.83. EPS for the following year is $1.59, with 15.0 analysts recommending between $2.88 and $1.11.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $221.03M this quarter.It ranges from a high estimate of $222.7M to a low estimate of $219.4M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $203.19MFor the next quarter, 17 analysts are estimating revenue of $264.6M. There is a high estimate of $266.7M for the next quarter, whereas the lowest estimate is $261.4M.
A total of 18 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $905.64M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $904.07M. In the same quarter a year ago, actual revenue was $802.8MBased on 18 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.07B and the low estimate is $1.01B.
